1 / 11

Bioprocess Technology

Upgrading the Value of Shale Gas on-site with Innovative Syngas Bioreactors ryan.johnson@curtislab.org (215) 272-0564. Bioprocess Technology. Calyx Bioprocess Technology. Scalable, low-capital cost bioconversion of syngas to chemicals

dee
Download Presentation

Bioprocess Technology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Upgrading the Value of Shale Gas on-site with Innovative Syngas Bioreactors ryan.johnson@curtislab.org (215) 272-0564 Bioprocess Technology

  2. Calyx Bioprocess Technology • Scalable, low-capital cost bioconversion of syngas to chemicals • Utilizing patented plastic-lined bioreactor • High-value products for enhanced revenue • Targeting unique biochemicals • High Quality Lubricants (wax-esters) • Petrochemical substitutes • Cosmetics • Targeting stranded gas and remote shale wells • Areas where gas infrastructure is uneconomical • Profit from current gas flaring sites • On-site gas liquefaction process • Remotely monitored bioreactor • No gas distribution infrastructure needed Wax Esters Potential increase in NG value per Billion cu. Ft. $3,000 (Transport Fuels: 167%) $60,000 (High Value Lubricants: 1,300%) $200,000+ (Cosmetics: 4,400%) Curtis WR, Growing cells in a reservoir formed of a flexible sterile plastic liner, U.S. Patent #6,709,862, March 23, 2004.

  3. How big is the opportunity? • Market Characteristics • Oil/gas Shale Boom • Volatile market and record-low natural gas prices • Expansive shale reserves • 100-200 Tcf recoverable • Estimated 7 billion cubic feet of natural gas flared in US (2011) • Current wells out of production • Many wells are not bringing gas to market due to economics • Decentralized and Remote well sites • Topography and vast area of PA prevents new gas distribution infrastructure eia.gov Remote gas reserves lacking infrastructure

  4. Experienced Team • Management Team (Chemical, Industrial, Biotech, Energy Engineers) • Dr. Wayne R. Curtis– President and CEO • 25+ years algae and plant biotechnology experience • PI on ARPA-E funded “Electrofuels” Project • Ryan Johnson– Engineering Manager, Biz Development • Bioreactor Scale-up, Process Control • Involved in CALYX entrepreneurial activities since 2011. • Product Quality Characterization • Dr. Alex Rajangam– Molecular Biotechnologist • 12+ Years experience in biomass energy, metabolic engineering of wax-ester biosynthetic pathways • Nymul Khan– Intern • Bioreactor Design Challenges • Genetic Screening • Technical Advisors • Dr. Harold Schobert– Renowned expert in gasification reactors and syngas conversion

  5. Why are we doing it? • Leveraging technology developed under ARPA-E Electrofuels program fixing biofuels from H2 and CO2 • High-efficiency conversion of gas phase to high quality biofuels • High-throughput chemical screening of genetically tailored organisms • Current syngas to liquids is based on 100 year old technology • Fischer-Tropsch liquefaction requires large-scale, high cost equipment • Current syngas bioreactor systems produce alcohols • Difficult product separation, lower value product line • Our group has experience with fatty acid wax esters • Wax esters are currently being marketed for high-value lubricants and cosmetics • Rapidly developing oil-shale with un-utilized “producer gas” • Flared gas in the U.S. is exponentially increasing (increased by $315 Million in potential revenue from 2010 to 2011)

  6. Technology Overview • A low-cost trickle-bed bioreactor is poised to be the only leading technology capable of upgrading natural gas to liquids at such a small scale • Genetic modifcation of Clostridium ljungdahlii with Jojoba wax ester pathway • 97+% biological conversion of gas • 87+% Conversion to product • 13% used for biological functions 97%+ Syngas Yield Requires 1 ) Zero outputs except BioFuel “Dead End Fermentation” 2) Ultra-Low Dilution Rate “Growth Disassociated Fuel Production” 3) Secreted Hydrophobic Product Plastic-Lined Lab-scale Trickle Bed Fermenter 100 Liter for scale-up parameters

  7. Syngas / Methane Fermenters INEOS (Bio) LanzaTech Coskata Alcohol Product Who else is doing this? Fischer Tropsch / Thermochemical $150,000 Qatar GTL Plastic-Lined Trickle Bed Carbon Sciences CapEx ($/BPD) High Temp • On-Site Conversion • High-value Product Line • Highest Conversion Efficiency $10,000 100 10,000 100,000 Capacity (BBL/day)

  8. Our Competitive Advantage • Centralized, large-scale processing still requires natural gas distribution infrastructure • On-site liquefaction requires minimal gas handling • Production of alcohol requires distillation • Our continuous process phase separates our product through decantation • Trickle-bed fermenters have ultra efficient gas-to-liquid mass transfer with minimal operational cost • Trickle-beds are much larger (90%) than conventional stirred tank fermenters • Our patent allows us to have maximum efficiency with minimal capital cost Minimal capital cost Maximum efficiency per Energy Input

  9. Economic Assessment • Conventional Small Scale FT-GTL CapEx is uneconomical • > 120,000 $/BPD • 55% of CapEx for Syngas Production • 35% of CapEx for Fischer-Tropsch • 10% of CapEx for Product Upgrading • 100 BBL/day commercial facility analyzed using ASPEN HYSYS • 25,000 m^3 CH4 / day (@ $4.54 / 1k ft^3) • 87% conversion of syngas to fuel • $5.6 MM for “Conventional” Trickle Bed Reactor (370 m^3) • Plastic Lined Reactor CapEx < $0.75 MM • High-value product line enables strong ROI • Operational + Fixed + Capital = $126/bbl • High-value lubricant product lines allow for ROR of > 322% • Does not include operational / capital of syngas reforming.

  10. Business Model and Strategy

  11. Strategic Partner Possibilities • Unique strategic partner for syngas production from methane • Steam reforming of Methane to syngas has been cost prohibitive at small to medium scale • Reduction is CapEx for small scale autothermal methane reforming is necessary for economics • The high specificity of transgenic bacteria allow our group to tailor products to our partners and customers • We have modified our current product lines (fuels) to include higher value lubricants. • We will seek to partner with synthetic lubricant manufacturer (such as Mobil-1) • Enable wax-ester product lines during scale-up • Further test product lines for higher value applications such as cosmetics High Value Lubricants Cosmetics Value Chain Shell GTL Facility

More Related